SINGAPORE, Aug. 26, 2022 — Pfizer has been ranked first in its Covid-19 response, patient centricity, patient safety and bringing innovative, high-quality products amongst pharma companies in Asia in the ‘Corporate Reputation of Pharma’ survey by patient groups across the APAC region.
Overall, the company is ranked second for its corporate
